Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Tumor Biology

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13277-013-1384-9PMID 24241960
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of pigment epithelium-derived factor and tumor necrosis factor-α is correlated in bladder tumor and is related to tumor angiogenesis.

  2013cited by this paper
• Relationship of TP53 and Ki67 expression in bladder cancer under WHO 2004 classification.

  2013cited by this paper
• BLCA-4 expression is related to MMP-9, VEGF, IL-1α and IL-8 in bladder cancer but not to PEDF, TNF-α or angiogenesis.

  2012cited by this paper
• Urinary BLCA-4 is highly specific for detection of bladder cancer in Chinese Han population and is related to tumour invasiveness.

  2011cited by this paper
• Biomarkers in bladder cancer

  2010cited by this paper
• Biomarkers in bladder cancer

  2010cited by this paper
• Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.

  2009cited by this paper
• Conservative management of low risk superficial bladder tumors.

  2008cited by this paper
• Molecular alterations associated with bladder cancer initiation and progression

  2008cited by this paper
• Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

  2007cited by this paper
• Bladder Cancer: Management and Future Directions

  2007cited by this paper
• Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

  2006cited by this paper
• Apoptotic and proliferation indexes in primary superficial bladder tumors.

  2006cited by this paper
• Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases

  2006cited by this paper
• Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder.

  2006influential reference
• Genetic and Immunophenotype Analyses of TP53 in Bladder Cancer: TP53 Alterations Are Associated with Tumor Progression

  2004cited by this paper
• A Population-based Study of 538 Patients with Newly Detected Urinary Bladder Neoplasms Followed during 5 Years

  2003cited by this paper
• Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder.

  2003cited by this paper
• Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder.

  2003cited by this paper
• Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy.

  2003cited by this paper
• Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network.

  2002cited by this paper
• International Union Against Cancer

  2002cited by this paper
• Loss of p63 expression is associated with tumor progression in bladder cancer.

  2002cited by this paper
• Relevance of p53 Gene Alterations for Tumor Recurrence in Patients with Superficial Transitional Cell Carcinoma of the Bladder

  2001cited by this paper
• Multivariate analysis of the prognostic factors of primary superficial bladder cancer.

  2000cited by this paper
• p63 and p73: p53 mimics, menaces and more

  2000cited by this paper
• MIB‐1 as a proliferative marker in transitional cell carcinoma of the bladder

  2000cited by this paper
• The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma.

  2000cited by this paper
• Treatment of Superficial Bladder Tumors: Achievements and Needs

  2000cited by this paper
• Evaluation of P53 Protein Overexpression, Ki67 Proliferative Activity and Mitotic Index as Markers of Tumour Recurrence in Superficial Transitional Cell Carcinoma of the Bladder

  2000cited by this paper
• Frequent alteration of p63 expression in human primary bladder carcinomas.

  2000cited by this paper
• Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort.

  1999cited by this paper
• Prognostic Value of MIB-1 Score, p53, EGFr, Mitotic Index and Papillary Status in Primary Superficial (Stage pTa/T1) Bladder Cancer: A Prospective Comparative Study

  1999cited by this paper
• The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

  1998cited by this paper
• The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder

  1998cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• Relationship of p53 and bcl-2 to prognosis in muscle-invasive transitional cell carcinoma of the bladder.

  1996cited by this paper
• p53 mutations have no additional prognostic value over stage in bladder cancer.

  1994cited by this paper
• Prognostic factors in bladder carcinoma: Histologic parameters and expression of a cell cycle‐related nuclear antigen (Ki‐67)

  1992cited by this paper

• AMIGO2 expression at the invasive front of bladder cancer predicts recurrence-free and overall survival after radical cystectomy

  2025cites this paper
• Prediction of Ki-67 expression in bladder cancer based on CT radiomics nomogram

  2024cites this paper
• Genome-Wide Screening Identifies Gene AKR1C1 Critical for Resistance to Pirarubicin in Bladder Cancer

  2023cites this paper
• A retrospective study on expression and clinical significance of PHH3, Ki67 and P53 in bladder exophytic papillary urothelial neoplasms

  2023cites this paper
• A study of the immunohistochemical profile of bladder cancer in neuro-urological patients by the French Association of Urology

  2022cites this paper
• Caveolin-1, GATA-3, and Ki67 expressions and their correlation with pathological findings in canine bladder urothelial carcinoma

  2022cites this paper
• A systematic review and meta-analysis of CK20, CD44, Ki67 and p53 as immunohistochemical markers in bladder carcinoma in situ.

  2022cites this paper
• Revisión sistemática y metaanálisis sobre CK20, CD44, Ki67 y p53 como marcadores inmunohistoquímicos en el carcinoma in situ vesical

  2022cites this paper
• Molecular determinants of recurrences of the human urothelial tumor

  2021cites this paper
• Frontiers in Bladder Cancer Genomic Research

  2021cites this paper
• The application of multidisciplinary therapy strategy of precision medicine in tumour diagnosis and treatment

  2021cites this paper
• Expression of E-cadherin, Ki-67, and p53 in urinary bladder cancer in relation to progression, survival, and recurrence

  2020cites this paper
• Correlation between immunohistochemical expression of Ki-67and P63 and aggressiveness of urinary bladder urothelial carcinoma

  2020influential citation
• Predictive Molecular and Protein Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer

  2019cites this paper
• FAM53A Affects Breast Cancer Cell Proliferation, Migration, and Invasion in a p53-Dependent Manner

  2019cites this paper
• Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status

  2019cites this paper
• Immunohistochemical characteristics of bladder cancer in patients with virus-positive tumors

  2018cites this paper
• Cell Cycle Markers in the Evaluation of Bladder Cancer

  2018cites this paper
• Ki-67 and Cell Cycle Regulators p53, p63 and cyclinD1 as Prognostic Markers for Recurrence/ Progression of Bladder Urothelial Carcinoma

  2018cites this paper
• CDCA8 expression and its clinical relevance in patients with bladder cancer

  2018influential citation
• Expression of PD-L 1 associated with Ki-67 and chemotherapy response but not p 53 in osteosarcoma

  2018cites this paper
• PROFILS MOLÉCULAIRES PRÉDICTIFS DU POTENTIEL MÉTASTATIQUE DU CARCINOME UROTHÉLIAL DE LA VESSIE DE STADE PT1 OU SUPÉRIEUR

  2017cites this paper
• Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder

  2017cites this paper
• Immunohistochemistry Biomarkers in Nonmuscle Invasive Bladder Cancer

  2017cites this paper
• Systemic inflammatory responses predict survival outcomes and male gender predicts metachronous bladder cancer of upper tract urothelial carcinoma

  2017cites this paper
• Expression of circular RNA circASXL1 correlates with TNM classification and predicts overall survival in bladder cancer.

  2017cites this paper
• FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression.

  2017cites this paper
• Prognostic value of HER-2/neu, Ki-67, MCM-2, and p21 expression in nonmuscle invasive bladder cancer

  2017cites this paper
• CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients

  2016cites this paper
• TFPI-2 expression is decreased in bladder cancer and is related to apoptosis.

  2016cites this paper
• ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC)

  2016cites this paper
• Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.

  2016cites this paper
• High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma

  2016cites this paper
• Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis

  2016cites this paper
• Expression of the p53 Inhibitors MDM2 and MDM4 as Outcome Predictor in Muscle-invasive Bladder Cancer.

  2016cites this paper
• Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy

  2016cites this paper
• Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy.

  2015cites this paper
• Copy Number Analysis of 24 Oncogenes: MDM4 Identified as a Putative Marker for Low Recurrence Risk in Non Muscle Invasive Bladder Cancer

  2014cites this paper
• Predictive Value of Clinicopathological Markers for the Metachronous Bladder Cancer and Prognosis of Upper Tract Urothelial Carcinoma

  2014cites this paper